Evidence map›Paper›PMID 42064870›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2026

Transcatheter tricuspid valve treatment: a growing armamentarium of devices.

Rodrigo Estevez-Loureiro, Julio Echarte-Morales, Nicole Karam, Axel Linke, Henryk Dreger, Xavier Freixa, Thomas Modine, Philip Lurz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rodrigo Estevez-LoureiroDepartment of Cardiology, University Hospital Alvaro Cunqueiro, Vigo, Spain.ORCID https://orcid.org/0000-0001-5841-5514
Julio Echarte-MoralesDepartment of Cardiology, University Hospital Alvaro Cunqueiro, Vigo, Spain.ORCID https://orcid.org/0000-0003-3951-6875
Nicole KaramClemenceau Medical Center, Cardiology Department, Beirut, Lebanon.
Axel LinkeDepartment of Internal Medicine and Cardiology, Herzzentrum Dresden, Universitätsklinik an der Technischen Universität Dresden, Dresden, Germany.
Henryk DregerDeutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Campus Virchow Klinikum, Berlin, Germany.
Xavier FreixaCardiology Department, Cardiovascular Institute (ICCV), Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
Thomas ModineDepartment of Cardiology and Cardio-Vascular Surgery, Hôpital Cardiologique de Haut-Leveque, Bordeaux University Hospital, Bordeaux, France.ORCID https://orcid.org/0000-0003-4169-3766
Philip LurzDepartment of Cardiology, University Medical Center of the Johannes Gutenberg, Mainz, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tricuspid regurgitation is a frequent and undertreated condition associated with poor outcomes. Over the past decade, transcatheter tricuspid valve interventions have emerged as a valuable alternative for high-risk patients. Edge-to-edge repair is the most widely adopted approach, while replacement technologies are advancing rapidly and offer the potential for near-complete elimination of regurgitation. In parallel, annuloplasty, spacers, and caval devices are broadening the therapeutic spectrum across diverse anatomies. This review outlines the expanding device armamentarium and the key opportunities and challenges in this evolving field.

Indexed as

AnnuloplastySpacerTranscatheter tricuspid valve interventionsTranscatheter tricuspid valve replacementTricuspid regurgitationTricuspid transcatheter edge-to-edge repair

Identifiers

PMID42064870
PMCPMC13128267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.